Evidence map›Paper›PMID 29725667›Full record

ArticleDigital biomarkers2017

Telehealth Management of Parkinson's Disease Using Wearable Sensors: An Exploratory Study.

Dustin A Heldman, Denzil A Harris, Timothy Felong, Kelly L Andrzejewski, E Ray Dorsey, Joseph P Giuffrida, Barry Goldberg, Michelle A Burack

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Digital biomarkers, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 6 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 6 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Televisits for Parkinson's disease: benefits and barriers.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  9. Review
  10. Economic evaluation of mHealth solutions in PD: where do we stand?Neurodegenerative disease management · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Dustin A HeldmanGreat Lakes NeuroTechnologies, Cleveland, OH, USA.
Denzil A HarrisSchool of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, USA.
Timothy FelongCenter for Human Experimental Therapeutics, University of Rochester Medical Center, Rochester, NY, USA.
Kelly L AndrzejewskiDepartment of Neurology, University of Rochester Medical Center, Rochester, NY, USA.
E Ray DorseyCenter for Human Experimental Therapeutics, University of Rochester Medical Center, Rochester, NY, USA.
Joseph P GiuffridaGreat Lakes NeuroTechnologies, Cleveland, OH, USA.
Barry GoldbergGreat Lakes NeuroTechnologies, Cleveland, OH, USA.
Michelle A BurackDepartment of Neurology, University of Rochester Medical Center, Rochester, NY, USA.
University of Rochester Medical Center · USGreat Lakes NeuroTechnologies (United States) · US

Funding

PDRemote: Automated Telehealth Diagnostics for Remote Parkinson's MonitoringR44MD004049 · NIMHD · GREAT LAKES NEUROTECHNOLOGIES · PI GIUFFRIDA, JOSEPH · 2012 to 2014
$1.2M
NIMHD NIH HHS R44 MD004049
6 · The paper itself

Abstract

backgroundParkinson's disease (PD) motor symptoms can fluctuate and may not be accurately reflected during a clinical evaluation. In addition, access to movement disorder specialists is limited for many with PD. The objective was to assess the impact of motion sensor-based telehealth diagnostics on PD clinical care and management.

methodsEighteen adults with PD were randomized to control or experimental groups. All participants were instructed to use a motion sensor-based monitoring system at home one day per week, for seven months. The system included a finger-worn motion sensor and tablet-based software interface that guided patients through tasks to quantify tremor, bradykinesia, and dyskinesia. Data were processed into motor symptom severity reports, which were reviewed by a movement disorders neurologist for experimental group participants. After three months and six months, control group participants visited the clinic for a routine appointment, while experimental group participants had a videoconference or phone call instead.

resultsHome based assessments were completed with median compliance of 95.7%. For a subset of participants, the neurologist successfully used information in the reports such as quantified response to treatment or progression over time to make therapy adjustments. Changes in clinical characteristics from study start to end were not significantly different between groups. DISCUSSION: Individuals with PD were able and willing to use remote monitoring technology. Patient management aided by telehealth diagnostics provided comparable outcomes to standard care. Telehealth technologies combined with wearable sensors have the potential to improve care for disparate PD populations or those unable to travel.

Identifiers

PMID29725667
PMCPMC5927622
OpenAlexW2624821470

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.